Lara Kujtan, MD

Articles by Lara Kujtan, MD

Dr. Kujtan on Frontline Therapy for EGFR-Positive NSCLC

February 6th 2019

Lara Kujtan, MD, assistant professor at the University of Missouri–Kansas City School of Medicine, discusses frontline therapy for patients with EGFR-positive non–small cell lung cancer (NSCLC).

Dr. Kujtan on Patient Preferences in the Treatment of NSCLC

ByLara Kujtan, MD

January 22nd 2019

Lara Kujtan, MD, assistant professor at the University of Missouri–Kansas City School of Medicine, discusses the importance of patient preferences in the treatment of oncogene-driven non-small cell lung cancer (NSCLC).